Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy

Tremelimumab is a fully human monoclonal antibody specific for human cytotoxic T lymphocyte-associated antigen 4. Administration of tremelimumab to patients with locally advanced and metastatic melanoma has resulted in a subset of patients with durable objective tumour regressions. Our echocardiogra...

Full description

Bibliographic Details
Main Authors: Sebastian Spethmann, Uwe Trefzer, Fabian Knebel
Format: Article
Language:English
Published: Karger Publishers 2014-02-01
Series:Case Reports in Dermatology
Subjects:
Online Access:http://www.karger.com/Article/FullText/360127